[Predictive pharmacodynamic criteria and efficacy of augmentin 1 g/125 mg in 2 doses per day].
Jehl
F
F
Laboratoire d'Antibiologie, Institut de Bactériologie, Hôpitaux Universitaires de Strasbourg.
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013810:Therapeutic Equivalency
D000900:Anti-Bacterial Agents; D019980:Amoxicillin-Potassium Clavulanate Combination